openPR Logo
Press release

Pharmaceutical Contract Sales Outsourcing [CSO] Market Overview and Growth Trends

02-15-2024 02:13 PM CET | Health & Medicine

Press release from: Transparency Market Research

Pharmaceutical Contract Sales Outsourcing [CSO] Market

Pharmaceutical Contract Sales Outsourcing [CSO] Market

The Pharmaceutical Contract Sales Outsourcing (CSO) market in North America has witnessed significant growth and is expected to continue its upward trajectory from 2022 to 2031. This article explores key insights, trends, and factors driving the market, including the increasing demand for outsourced sales teams in the pharmaceutical industry.

The North America Pharmaceutical Contract Sales Outsourcing (CSO) market was valued at US$ 2.6 billion in 2021, with a projected CAGR of 7.4% from 2022 to 2031. By the end of 2031, the market is anticipated to reach over US$ 5.2 billion, showcasing substantial growth opportunities.

Download PDF Brochure: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=85183

Impact of COVID-19:

The pharmaceutical industry, facing pressures due to the coronavirus outbreak, has turned to CSOs to enhance production capabilities for vaccines and other treatment options. Outsourcing sales processes has become a strategic choice for U.S. pharmaceutical companies, aiming to save time, cut costs, and alleviate administrative burdens on internal management teams.

Driving Factors for CSO Market Growth:

a. R&D Investments:

Medium and large pharmaceutical companies are outsourcing sales operations to control costs, achieve better results, and maintain operational flexibility amid rising R&D and operating costs.

b. Digitalization:

CSOs are playing a crucial role in the digital transformation of pharmaceutical services, offering advanced non-personal promotion strategies and virtual detailing to enhance market recognition.

Place an Order Copy of North America Pharmaceutical Contract Sales Outsourcing [CSO] Market Report at:

https://www.transparencymarketresearch.com/checkout.php?rep_id=85183<ype=S

Service Segmentation:

The market is segmented into Personal Promotion, Non-personal Promotion, and Others. Non-personal Promotion is identified as the fastest-growing segment, driven by the shift from personal interaction to phone and e-detailing, aligning with brands' omnichannel marketing strategies.

Therapeutic Area Focus:

The Pharmaceutical Contract Sales Outsourcing market in North America is categorized based on therapeutic areas, with a notable focus on oncology. The increase in the number of cancer patients is driving the demand for outsourcing drug formulation development and sales operations in this segment.

Key Players and Collaborations:

Major players such as Ashfield, Granard Pharmaceutical Sales & Marketing, Syneos Health, Amplity Health, IQVIA, and EVERSANA dominate the market. Strategic alliances, diversification of product portfolios, and mergers & acquisitions are prominent strategies to increase revenue and market share.

Notable Developments:

Recent collaborations, like IQVIA's partnership with Janssen Research & Development for COVID-19 vaccine clinical trials, and Ashfield Engage's partnership with Popit to improve patient adherence, showcase the industry's commitment to innovation and patient-centric approaches.

More Trending Reports by Transparency Market Research -

Point-of-Care (POC) Coagulation Testing Devices Market

https://www.globenewswire.com/en/news-release/2022/07/25/2485292/0/en/Point-of-Care-POC-Coagulation-Testing-Devices-Market-Expands-with-Rising-Use-of-Anticoagulant-Therapy-in-Treatment-of-Different-Chronic-Diseases-Notes-TMR-Study.html

Robotic Rehabilitation and Assistive Technologies Market

https://www.globenewswire.com/en/news-release/2022/07/20/2482930/0/en/Robotic-Rehabilitation-and-Assistive-Technologies-Market-to-Surpass-Value-of-US-5-5-Bn-by-2031.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact:

Nikhil Sawlani
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pharmaceutical Contract Sales Outsourcing [CSO] Market Overview and Growth Trends here

News-ID: 3386483 • Views:

More Releases from Transparency Market Research

Medical Device Technologies Market Outlook 2035: Revolutionizing Healthcare Through Innovation and Digital Integration
Medical Device Technologies Market Outlook 2035: Revolutionizing Healthcare Thro …
The global medical device technologies market is entering a transformative era marked by the convergence of engineering, biotechnology, and digital innovation. Valued at US$ 487.5 billion in 2024, the market is projected to grow at a compound annual growth rate (CAGR) of 5.5% from 2025 to 2035, reaching an impressive US$ 882.1 billion by the end of 2035. This steady expansion is driven by rising healthcare demands, aging populations, increasing prevalence
Respiratory Monitoring Devices Market Outlook 2035: Driving Innovation in Pulmonary Health and Critical Care
Respiratory Monitoring Devices Market Outlook 2035: Driving Innovation in Pulmon …
The global respiratory monitoring devices market is experiencing strong growth as the prevalence of respiratory disorders continues to rise worldwide. Valued at US$ 15.4 billion in 2024, the global industry is projected to grow at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2035, reaching approximately US$ 43.3 billion by the end of 2035. This impressive expansion is driven by increasing incidences of chronic respiratory diseases (CRDs) such
Cell Culture Market Outlook 2035: Powering the Future of Biotechnology, Regenerative Medicine, and Drug Discovery
Cell Culture Market Outlook 2035: Powering the Future of Biotechnology, Regenera …
The global cell culture market is witnessing remarkable expansion as it becomes a cornerstone technology in biopharmaceutical manufacturing, regenerative medicine, vaccine development, and tissue engineering. Valued at US$ 28.2 billion in 2024, the global cell culture industry is projected to grow at a compound annual growth rate (CAGR) of 9.7% from 2025 to 2035, reaching US$ 78.2 billion by the end of 2035. This growth is being driven by rapid advancements
Equine Healthcare Market Outlook 2035: Advancing Veterinary Medicine for Enhanced Equine Well-Being and Performance
Equine Healthcare Market Outlook 2035: Advancing Veterinary Medicine for Enhance …
The global equine healthcare market is gaining steady momentum, driven by growing awareness of animal welfare, increasing investments in veterinary diagnostics, and the rising economic significance of horses in sports, recreation, and therapy. Valued at US$ 0.8 billion in 2024, the industry is projected to expand at a compound annual growth rate (CAGR) of 4.8% from 2025 to 2035, reaching over US$ 1.3 billion by the end of 2035. The market's

All 5 Releases


More Releases for CSO

Pharmaceutical CSO Market Grows As Firms Seek Scalable Salesforce Solutions
Pharmaceutical Contract Sales Outsourcing [CSO] Market Overview The Pharmaceutical Contract Sales Outsourcing (CSO) Market is projected to grow from USD 9.4 Billion in 2025 to USD 16.3 Billion by 2032, at a CAGR of 8.1% during the forecast period. Coherent Market Insights is pleased to release its latest Pharmaceutical Contract Sales Outsourcing [CSO] Market research report, offering an in-depth analysis of the U.S. Pharmaceutical Contract Sales Outsourcing [CSO] Market Landscape from 2025
Pharmaceutical Contract Sales Outsourcing [CSO] Market: Revolutionizing Pharmace …
The pharmaceutical contract sales outsourcing (CSO) market has witnessed substantial growth in recent years, driven by the increasing demand for efficient sales strategies amidst the COVID-19 pandemic. With the spotlight on vaccine production and treatment options, pharmaceutical companies are turning to CSO to meet consumer and healthcare facility demands. The market is projected to expand at a favorable CAGR of ~7% during the forecast period, with a surge in outsourcing
Pharmaceutical Contract Sales Outsourcing [CSO] Market Overview and Growth Trend …
The Pharmaceutical Contract Sales Outsourcing (CSO) market in North America has witnessed significant growth and is expected to continue its upward trajectory from 2022 to 2031. This article explores key insights, trends, and factors driving the market, including the increasing demand for outsourced sales teams in the pharmaceutical industry. The North America Pharmaceutical Contract Sales Outsourcing (CSO) market was valued at US$ 2.6 billion in 2021, with a projected CAGR of
Business Centre Market is Going to Boom | Regus, CSO, Servcorp
HTF MI introduce new research on Business Centre covering micro level of analysis by competitors and key business segments (2021-2027). The Business Centre explores comprehensive study on various segments like opportunities, size, development, innovation, sales and overall growth of major players. The research is carried out on primary and secondary statistics sources and it consists both qualitative and quantitative detailing. Some of the MajorKey players profiled in the study are
Andreas Beerbaum (CSO) is leaving SeeTec
Facing a new professional challenge, Andreas Beerbaum, Chief Sales Officer at SeeTec AG, will leave the company in August by his own request. Stephan Rasp, Chief Executive Officer at SeeTec, thanks him for his commitment during the past five years: „As a member of the board Andreas Beerbaum had a great impact on preparing SeeTec for our future success. He was leading in pushing the development and implementation of our
dinCloud CSO to Discuss Cloud ROI at Cloud4SMB Expo
Saad Shahzad to Share Expertise at Technology Conference Focused on SMB Opportunities in the Cloud LOS ANGELES, CA & AUSTIN, TX – September 19, 2012 – dinCloud, a cloud transformation company, today announced that Chief Strategy Officer Saad Shahzad will join executives from IBM, Intuit, and LevelCloud to discuss “Squeezing Dollars from the Cloud – What’s the ROI?” at Cloud4SMB Expo in Austin, Texas on Wednesday, October 3rd from 11-11:45am. An increasing